Product Information
METHIMAZOLE 10 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1246 per EA under NDC 64980026501. Its NADAC has been published 172 times since May 10, 2023.
FDA first approved this application on Mar 7, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980026501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202068FDA Approved
3/7/2012
TE Code
AB
On Market Since
4/22/2021
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 10 MG TABLET has been published 172 times since May 10, 2023, and over the history we have for it it has risen 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1246 per EA |
|---|---|
| All-time high | $0.2099 (Sep 13, 2023) |
| All-time low | $0.1062 (Nov 20, 2024) |
| 52-week high | $0.1339 |
| 52-week low | $0.1163 |
| Median price | $0.1300 |
| Average price | $0.1404 |
| Largest weekly change | +56.7% (May 17, 2023) |
| Weeks tracked | 172 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHIMAZOLE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 10 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1246 per EA (NDC 64980026501), effective Aug 19, 2026.
How has the price of METHIMAZOLE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 10 MG TABLET has risen 14.2%. It has been tracked across 172 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 10 MG TABLET?
Since May 10, 2023, the NADAC for METHIMAZOLE 10 MG TABLET has ranged from a low of $0.1062 (Nov 20, 2024) to a high of $0.2099 (Sep 13, 2023), with a median of $0.1300 per EA.
Are there cheaper alternatives to METHIMAZOLE 10 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHIMAZOLE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHIMAZOLE 10 MG TABLET?
METHIMAZOLE 10 MG TABLET (NDC 64980026501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.